4.8 Review

Pleiotropic Roles for ZEB1 in Cancer

期刊

CANCER RESEARCH
卷 78, 期 1, 页码 30-35

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-17-2476

关键词

-

类别

资金

  1. Region Rhones-Alpes
  2. Institut National du Cancer [PLBI009]
  3. Lyon Integrated Research Institute in Cancer (LYRIC)
  4. LabEx DEVweCAN of Lyon University [ANR-10-LABX-0061, ANR-11-IDEX-0007]
  5. Fondation de France [67134]
  6. Ligue Nationale Contre le Cancer

向作者/读者索取更多资源

ZEB1 is a prime element of a network of transcription factors that controls epithelial-to-mesenchymal transition (EMT), a reversible embryonic transdifferentiation program that allows partial or complete transition from an epithelial to a mesenchymal state. Aberrant expression of ZEB1 has been reported in a variety of human cancers, where it is generally believed to foster migration, invasion, and metastasis. Over the past few years, in vitro and in vivo observations have highlighted unsuspected intrinsic oncogenic functions of ZEB1 that impact tumorigenesis from its earliest stages. Located downstream of regulatory processes that integrate microenvironmental signals and directly implicated in feedback loops controlled by miRNAs, ZEB1 appears to be a central switch that determines cell fate. Its expression fosters malignant transformation through the mitigation of critical oncosuppressive pathways and through the conferment of stemness properties. ZEB1 is also a key determinant of cell plasticity, endowing cells with the capacity to withstand an aberrant mitogenic activity, with a profound impact on the genetic history of tumorigenesis, and to adapt to the multiple constraints encountered over the course of tumor development. (C) 2017 AACR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据